Introducing an innovative new treatment option for DVA Patients. Fully funded if eligible and approved by the DVA.
GoodMind Therapeutics is able to offer a cutting-edge treatment option utilising a new intranasal medicine, recently registered on the ARTG, for eligible DVA patients facing treatment-resistant symptoms.
This treatment may be suitable for you if you have tried two or more conventional medications in your current episode of low mood or feelings of despair without experiencing the desired relief.
This therapy is currently administered only in our Sydney CBD clinic. However, we are opening a clinic in Brisbane soon, with other clinics opening on the Gold Coast and in Townsville (Qld), and in Newcastle and the Central Coast (N.S.W.)
We are screening for all the above areas so please register your interest below and we will contact you with more details and a link to our screening form.
Fill in the form below to register your interest and look out for an email with further details including the screening process and eligibility.
Full funding of this therapy is possible if approved by the DVA on a case-by-case basis.
The cost of treatment may be fully-funded by the DVA for eligible patients if approved, and on a case-by-case basis. Our team will discuss details with you following your screening submission.
At this stage, treatment is administered in Sydney. However, we are now also accepting screenings for the Central Coast (NSW), The Gold Coast (Qld) and Townsville.
Eligible patients embarking on this journey will undergo a structured screening and treatment program, comprising three essential phases.
You must complete an initial screening with a Nurse Practitioner, and then a Psychiatrist.
Please fill in the form on this page and one of our medical practitioners will be in touch to start the process.
Over four weeks, patients will engage in 2 sessions per week to initiate their treatment journey.
Following induction, patients transition to a maintenance phase, attending 1 session per week for 4 weeks to sustain their progress.
As treatment progresses beyond the initial 8 weeks, the frequency of sessions will be individually tailored, occurring either weekly or fortnightly to accommodate the patient’s evolving needs while ensuring continued therapeutic response.
Under the careful guidance of our qualified medical personnel, patients will receive thorough monitoring throughout the administration of the intranasal medication post-treatment. For the safety and well-being of our patients, driving following treatment sessions is not permitted.
“ Our goal is to help individuals overcome their challenges and live more meaningful, fulfilling lives.
The GoodMind Therapeutics clinic offers: